Life360
LIF
39.51
-2.50
-5.95%
Life360
US · LIF
#2383 by market cap
Listed 2024
39.51
-2.50
-5.95%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.72, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +31.76% YoY
Margins
- Gross margin
- 77.81%
- Operating margin
- 3.88%
- Net margin
- 30.81%
Key ratios & quality
- Altman Z-Scorei
- 5.72
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | 80.66M | 112.64M | 228.31M | 304.52M | 371.48M | 489.48M |
| Gross profit | -- | 58.94M | 65.26M | 89.88M | 148.60M | 222.64M | 279.16M | 380.84M |
| Selling & admin expenses | -- | 43.18M | 42.27M | 71.14M | 140.53M | 151.66M | 174.06M | 233.45M |
| Research & development | -- | 32.14M | 39.64M | 50.99M | 102.48M | 100.97M | 113.07M | 128.41M |
| Operating profit | -- | -29.01M | -16.65M | -32.26M | -94.41M | -29.98M | -7.98M | 18.98M |
| Pretax profit | -- | -28.95M | -16.33M | -33.68M | -91.32M | -27.56M | -4.63M | 32.66M |
| Tax | -- | 0 | 0 | -127.00K | 312.00K | 616.00K | -71.00K | -118.17M |
| Net profit | -- | -28.95M | -16.33M | -33.56M | -91.63M | -28.17M | -4.56M | 150.83M |
| Basic EPS | -- | 0 | 0 | -1 | -1 | 0 | 0 | 2 |
| Diluted EPS | -- | -0.28 | -0.33 | -0.65 | -1.50 | -0.42 | -0.06 | 1.77 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 115.38M | 124.50M | 145.98M | 143.12M | 158.96M | 174.14M |
| Gross profit | 90.50M | 97.14M | 109.66M | 110.56M | 126.90M | 133.99M |
| Selling & admin expenses | 56.25M | 59.03M | 67.21M | 79.37M | 79.56M | 85.41M |
| Research & development | 32.26M | 32.41M | 33.34M | 39.27M | 47.40M | 40.61M |
| Operating profit | 1.99M | 5.69M | 9.11M | -8.08M | -57.00K | 7.97M |
| Pretax profit | 6.61M | 10.22M | 11.66M | -8.91M | 1.08M | 28.45M |
| Tax | -392.00K | 427.00K | -117.99M | -11.68M | -3.98M | 5.96M |
| Net profit | 7.01M | 9.79M | 129.66M | 2.78M | 5.06M | 22.49M |
| Basic EPS | 0 | 0 | 2 | 0 | 0 | 0 |
| Diluted EPS | 0.08 | 0.11 | 1.52 | 0.03 | 0.06 | 0.26 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 109.90M | 79.24M | 78.85M | 256.68M | 142.66M | 131.43M | 240.99M | 606.10M |
| Cash & ST investments | 100.60M | 63.82M | 56.41M | 230.99M | 75.44M | 68.96M | 159.24M | 494.26M |
| Inventory | -- | -- | -- | 2.01M | 10.83M | 4.10M | 8.06M | 9.87M |
| Total assets | 112.30M | 85.54M | 86.31M | 302.38M | 339.63M | 321.72M | 441.58M | 959.69M |
| Total current liabilities | 12.80M | 12.21M | 19.51M | 41.45M | 87.65M | 70.82M | 77.34M | 96.79M |
| Short-term debt | 1.60M | -- | 1.46M | 5.80M | 4.33M | 3.45M | -- | -- |
| Long-term debt | 3.30M | -- | -- | 8.28M | 4.06M | 1.06M | -- | 310.39M |
| Total liabilities | 17,200,000.00 | 13,265,000.00 | 21,818,000.00 | 52,331,000.00 | 95,092,000.00 | 74,653,000.00 | 83,035,000.00 | 411,506,000.00 |
| Total equity | 95.10M | 72.28M | 64.50M | 250.05M | 244.54M | 247.06M | 358.55M | 548.18M |
| Retained earnings | -87.30M | -115.45M | -131.79M | -165.34M | -256.97M | -285.14M | -289.70M | -138.87M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 521.21M | 556.99M | 606.10M | 590.02M | 599.50M | 612.37M |
| Cash & ST investments | 432.71M | 455.73M | 494.26M | 457.30M | 464.98M | 462.39M |
| Inventory | 9.67M | 14.14M | 9.87M | 15.14M | 14.71M | 16.76M |
| Total assets | 753.58M | 787.45M | 959.69M | 1.04B | 1.05B | 1.09B |
| Total current liabilities | 72.95M | 81.94M | 96.79M | 109.84M | 107.04M | 115.31M |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | 309.30M | 309.84M | 310.39M | 310.93M | 311.48M | 312.02M |
| Total liabilities | 386,921,000.00 | 396,007,000.00 | 411,506,000.00 | 443,244,000.00 | 438,488,000.00 | 455,123,000.00 |
| Total equity | 366.66M | 391.45M | 548.18M | 597.63M | 613.43M | 630.57M |
| Retained earnings | -278.31M | -268.52M | -138.87M | -136.09M | -131.03M | -108.54M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -7.25M | -12.15M | -57.06M | 7.52M | 32.61M | 88.63M |
| Depreciation & amortization | -- | -- | 657.00K | 876.00K | 9.20M | 9.98M | 10.11M | 13.68M |
| Free cash flow | -- | -30.52M | -7.90M | -12.23M | -57.76M | 5.30M | 27.48M | 81.12M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | 76.23M | 0 | 193.06M | 32.22M | 0 | 93.00M | 0 |
| Ending cash balance | -- | 64.07M | 56.61M | 231.35M | 90.37M | 70.71M | 160.46M | 495.83M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | 13.32M | 26.45M | 36.80M | 17.21M | 23.81M | 27.13M |
| Depreciation & amortization | 3.16M | 4.02M | 3.56M | 5.51M | 5.72M | 6.23M |
| Free cash flow | 10.58M | 24.61M | 35.40M | 15.62M | 22.85M | 25.67M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | 0 | 0 | -- | -- | -31.22M |
| Ending cash balance | 434.23M | 457.23M | 495.83M | 352.86M | 269.75M | 335.78M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -34.60 | -23.89 | -21.31 | -37.03 | -11.46 | -1.50 | 33.27 |
| ROA %i | -- | -29.27 | -19.01 | -17.23 | -28.51 | -8.52 | -1.19 | 21.53 |
| ROIC %i | -- | -33.68 | -23.10 | -20.20 | -35.40 | -11.14 | -1.50 | 23.10 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -25.67 | -19.05 | -7.62 |
| EBIT margin %i | -- | -48.79 | -20.64 | -29.02 | -41.35 | -9.85 | -2.15 | 3.88 |
| FCF / sales %i | -- | -- | -- | -- | -- | 1.74 | 7.40 | 16.57 |
| Current ratioi | 8.59 | 6.49 | 4.04 | 6.19 | 1.63 | 1.86 | 3.12 | 6.26 |
| Quick ratioi | 8.30 | 5.88 | 3.36 | 5.88 | 1.26 | 1.58 | 2.85 | 5.96 |
| Debt / assetsi | 4.36 | 0.13 | 3.55 | 4.75 | 2.47 | 1.63 | 0.08 | 32.34 |
| LT debt / equityi | 3.47 | 0.15 | 2.49 | 3.43 | 1.66 | 0.72 | 0.10 | 56.62 |
| Interest coveragei | -- | -149.80 | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | 57.05 | 55.71 | 48.85 | 28.95 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | 7.95 | 8.12 | 33.27 | 30.65 | 30.06 | 31.31 |
| ROA %i | 4.76 | 4.89 | 21.53 | 19.95 | 16.32 | 17.08 |
| ROIC %i | 5.50 | 5.70 | 23.10 | 21.76 | 17.10 | 18.24 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 1.16 | 3.40 | 3.88 | 1.65 | 1.16 | 1.44 |
| FCF / sales %i | 8.65 | 12.25 | 16.57 | 16.30 | 17.20 | 16.00 |
| Current ratioi | 7.14 | 6.80 | 6.26 | 5.37 | 5.60 | 5.31 |
| Quick ratioi | 6.79 | 6.41 | 5.96 | 5.04 | 5.28 | 4.97 |
| Debt / assetsi | 41.07 | 39.36 | 32.34 | 29.87 | 29.61 | 28.74 |
| LT debt / equityi | 84.40 | 79.17 | 56.62 | 52.03 | 50.78 | 49.48 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Life360 discussion 0 comments